Form 4: Absci Director Menelas Pangalos Granted Significant Equity and Stock Options
Insider Transaction Report
Absci Corp Director Menelas N Pangalos has been granted 14,500 Restricted Stock Units and 57,400 stock options, aligning his interests with the company's long-term performance.
Summary
- Director Menelas N Pangalos of Absci Corp (ABSI) was granted 14,500 shares of Common Stock in the form of Restricted Stock Units (RSUs) on June 11, 2025, at a price of $0 per share.
- Following this transaction, Mr. Pangalos beneficially owns 18,175 shares of Common Stock.
- The RSUs are set to vest and settle in full on the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders, contingent on continuous service.
- Additionally, Mr. Pangalos was granted 57,400 stock options on June 11, 2025, with an exercise price of $3.01 per share.
- These stock options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders, also subject to continuous service.
- The stock options have an expiration date of June 10, 2035.
- After this transaction, Mr. Pangalos beneficially owns 57,400 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The grant of equity and options to a director is generally a positive signal, indicating alignment of interests and incentivizing long-term performance. It's a routine compensation event but still reflects commitment.
Positives
- The grant of Restricted Stock Units and stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
- The acquisition of equity by a director can signal confidence in the company's future prospects.
Future Outlook
The vesting schedules for both the Restricted Stock Units and stock options are tied to the director's continuous service, either for one year from the grant date or until the next annual meeting of stockholders, indicating an expectation of continued commitment and contribution.
Industry Context
This Form 4 filing reflects a standard practice of compensating directors with equity and options, a common mechanism across various industries, particularly in growth-oriented sectors like biotechnology, to align leadership incentives with shareholder value creation.
Related Party Transactions
- The grant of 14,500 Restricted Stock Units and 57,400 stock options to Director Menelas N Pangalos constitutes a related party transaction, as it involves the company providing compensation to a member of its board.
Stakeholder Impact
- Shareholders: The equity grants align the director's financial interests with the company's stock performance, potentially leading to decisions that enhance shareholder value.
- Employees: While not directly impacted, such compensation practices can set precedents for executive and director remuneration within the company.
Next Steps
- The Restricted Stock Units and stock options will vest based on the specified conditions (earlier of first anniversary of grant or next annual meeting of stockholders), subject to continuous service.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of transaction for the acquisition of Restricted Stock Units and Stock Options. |
| 06/12/2025 | Date of signature for the SEC Form 4 filing. |
| 06/10/2035 | Expiration date for the granted stock options. |
Keywords
Absci Corp, ABSI, Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Director Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.